MEI Pharma News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

28.03.17	MEI Pharma to Present at Needham Healthcare Conference (PR Newswire)
14.03.17	MEI Pharma to Present at Oppenheimer Healthcare Conference (PR Newswire)
05.12.16	Helsinn Group and MEI Pharma Report Prolongation of Survival Results from Phase 2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia (PR Newswire)
05.12.16	Helsinn Group and MEI Pharma Report Prolongation of Survival Results from Phase 2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia (PR Newswire)
12.12.14	MEI Pharma Prices $40 Mln Stock Offering (RTTNews)
09.12.14	New Use For AMGN's Old Drug, BLUE In The Pink, Cellceutix Gets A Boost (RTTNews)
06.05.14	MusclePharm Flexes Muscles, PRTA Surges After-hours, TXMD Hopes To Deliver (RTTNews)
28.02.14	MEI Pharma Gets Orphan Drug Status For Pracinostat For Acute Myeloid Leukemia (RTTNews)
15.01.14	CHTP Passes FDA Panel Test, DSCI Gets Skin Lift, MEIP, OncoSec To Watch Out For (RTTNews)
21.10.13	MEI Announces Results From Phase 1 Study Of Mitochondrial Inhibitor ME-344 (RTTNews)
21.10.13	MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Preliminary Evidence of Single-Agent Activity in First-in-Human Clinical Study (PR Newswire)
10.10.13	MEI Pharma Reports Topline Data From Phase I Trial Of ME-344 - Quick Facts (RTTNews)
17.09.13	MEI Pharma to Present at BioCentury's NewsMakers in the Biotech Industry Conference (PR Newswire)
05.09.13	MEI Pharma CEO to Present at Stifel Healthcare Conference (PR Newswire)
01.08.13	MEI Pharma CEO To Present At Wedbush Life Sciences Management Access Conference (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	597.60	2.68 %	K V
Novartis	96.09	0.53 %	K V
Nestle	77.86	0.49 %	K V
Roche Hldg G	285.70	-0.10 %	K V
Zurich Insur Gr	553.20	-0.11 %	K V
UBS Group	31.79	-1.70 %	K V
ABB	49.03	-1.84 %	K V
Kuehne+Nagel Int	203.20	-2.12 %	K V
Sika	227.60	-2.44 %	K V
Logitech Intl	88.62	-3.13 %	K V